These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 28608970)

  • 1. Effect of extended oral contraception use on the prevalence of fetal trisomy 21 in women aged at least 35 years.
    Horányi D; Babay LÉ; Rigó J; Győrffy B; Nagy GR
    Int J Gynaecol Obstet; 2017 Sep; 138(3):261-266. PubMed ID: 28608970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower risk for Down syndrome associated with longer oral contraceptive use: a case-control study of women of advanced maternal age presenting for prenatal diagnosis.
    Nagy GR; Győrffy B; Nagy B; Rigó J
    Contraception; 2013 Apr; 87(4):455-8. PubMed ID: 23040130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Longer oral contraception history as a possible preventive factor against fetal trisomy 21 in advanced maternal age pregnancies].
    Horányi D; Babay LÉ; Győrffy B; Nagy GR
    Orv Hetil; 2018 Jul; 159(28):1146-1152. PubMed ID: 29983104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening for congenital anomalies in mid-term pregnancy. Prospective epidemiologic study. Fetal trisomy].
    Tóth-Pál E; Oroszné Nagy J; Papp C; Szabó M; Veress L; Török O; Tóth Z; Papp Z
    Orv Hetil; 1995 Feb; 136(9):483-9. PubMed ID: 7535413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception.
    Balogh A; Ditrói F; Lampé LG
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():95-101. PubMed ID: 6242699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unexpected high frequency of trisomic fetuses in 229 pregnancies monitored for advanced maternal age.
    Sachs ES; Jahoda MG; Niermeijer MF; Galjaard H
    Hum Genet; 1977 Apr; 36(1):43-6. PubMed ID: 140145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal age- and gestation-specific risk for trisomy 21.
    Snijders RJ; Sundberg K; Holzgreve W; Henry G; Nicolaides KH
    Ultrasound Obstet Gynecol; 1999 Mar; 13(3):167-70. PubMed ID: 10204206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-specific incidences of chromosome abnormalities at the second trimester amniocentesis for Japanese mothers aged 35 and older: collaborative study of 5484 cases.
    Yaegashi N; Senoo M; Uehara S; Suzuki H; Maeda T; Fujimori K; Hirahara F; Yajima A
    J Hum Genet; 1998; 43(2):85-90. PubMed ID: 9621511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal pyelectasis: does fetal gender modify the risk of major trisomies?
    Bornstein E; Barnhard Y; Donnenfeld A; Ferber A; Divon MY
    Obstet Gynecol; 2006 Apr; 107(4):877-9. PubMed ID: 16582126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trisomic pregnancy and earlier age at menopause.
    Kline J; Kinney A; Levin B; Warburton D
    Am J Hum Genet; 2000 Aug; 67(2):395-404. PubMed ID: 10873791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The maternal age-specific live birth prevalence of trisomies 13 and 18 compared to trisomy 21 (Down syndrome).
    Savva GM; Walker K; Morris JK
    Prenat Diagn; 2010 Jan; 30(1):57-64. PubMed ID: 19911411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term outcomes after second-trimester genetic amniocentesis in Siriraj Hospital.
    Anuwutnavin S; Chanprapaph P; Ruangvutilert P; Eammatta M; Tontisirin P
    Int J Gynaecol Obstet; 2014 Mar; 124(3):222-5. PubMed ID: 24380612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester fetal nuchal translucency thickness and risk for trisomies.
    Pandya PP; Brizot ML; Kuhn P; Snijders RJ; Nicolaides KH
    Obstet Gynecol; 1994 Sep; 84(3):420-3. PubMed ID: 8058241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-trimester maternal pregnancy-associated plasma protein a and inhibin a levels in fetal trisomies.
    Watanabe H; Hamada H; Yamada N; Ogura T; Yasuoka MO; Okuno S; Fujiki Y; Sohda S; Kubo T
    Fetal Diagn Ther; 2002; 17(3):137-41. PubMed ID: 11914564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trisomy in man.
    Hassold TJ; Jacobs PA
    Annu Rev Genet; 1984; 18():69-97. PubMed ID: 6241455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
    Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
    Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women's knowledge of taking oral contraceptive pills correctly and of emergency contraception: effect of providing information leaflets in general practice.
    Smith LF; Whitfield MJ
    Br J Gen Pract; 1995 Aug; 45(397):409-14. PubMed ID: 7576845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal use of oral contraceptives and Down syndrome.
    Källén B
    Contraception; 1989 May; 39(5):503-6. PubMed ID: 2524361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.